Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02844465 · ClinicalTrials.gov registry record · NA

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

A NA study, sponsored by MedtronicNeuro.

Completed
Registry status
NA
Development phase
167
Enrollment target

NCT02844465: Completed NA study, sponsored by MedtronicNeuro.

NCT02844465 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 167 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02844465, a NA study, has completed, sponsored by MedtronicNeuro.

COMPLETED
Registry status
NA
Development phase
167 participants
Enrollment target

Study Summary

The study is designed to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for mesial temporal epilepsy (MTLE).

Primary Outcome

The incidence of qualifying device, procedure and/or anesthesia related adverse events. These events must also be moderate or severe and permanent for the following AEs: anxiety, aphasia, blurry vision, depression, diplopia, emotional lability, hemianopia, hemiparesis, memory impairment/difficulty, neurologic deficits, paralysis, psychological/psychiatric complications, quadrantanopia, sensory loss, sleep problems or insomnia. An exact 95% confidence interval (CI) will be calculated to determine

Interventions

  • DEVICE Visualase MRI-Guided Laser Ablation

Trial Details

FieldValue
Enrollment Target 167 participants
Start Date 2016-12
Est. Completion 2023-12-11
Phase NA
MedtronicNeuro

51 total trials

What the finished NCT02844465 record still lists

NCT02844465 is an interventional study that assigns participants to a tested intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which Visualase MRI-Guided Laser Ablation is the first listed.

NCT02844465 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02844465 about?

NCT02844465 is a clinical study titled "Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)". The study is designed to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for mesial temporal epilepsy (MTLE).

What is the current status of trial NCT02844465?

This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2016-12. Estimated completion is 2023-12-11.

What interventions are being tested in trial NCT02844465?

The interventions under investigation include: Visualase MRI-Guided Laser Ablation (DEVICE).

Who is sponsoring clinical trial NCT02844465?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02844465's enrollment target sits among peer trials

167 622nd of 2000 higher than 1,376 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04248283 · 167 participants · NA

    Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

  • NCT04552509 · 167 participants · NA

    TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer

  • NCT05516277 · 167 participants · NA

    Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02844465, the US trial registry maintained by the National Library of Medicine. NCT02844465 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.